Caspase Inhibitors as Molecular Probes of Cell Death

  • Apurva Sarin
  • Klaus Ebnet
  • Charles M. Zacharchuk
  • Pierre A. Henkart


Recognition of the importance of programmed cell death in basic biological processes as well as its relevance to clinical problems has led to a surge of research interest in this area in recent years. The appealing idea behind much of this research is that an endogenous death pathway is present in most cells which can be triggered to kill cells by physiological signals or when they encounter some types of stressful conditions. In spite of the rapid progress made in some respects, fundamental issues in this field remain unresolved, and the major challenge is still to molecularly characterize this death pathway and understand the controls which lead to its activation. Recent research in a number of laboratories has identified a family of enzymes which at very least now provides a testable candidate for a central player in such physiological death pathways. Specific inhibitors of these enzymes are newly available tools which can be used to test for their participation in particular physiological and experimental cell death systems (Henkart, 1996). In this paper we will present examples illustrating their use from our own studies on lymphoid cells. For reasons which will become clear, we believe that a functional death criterion based on inhibiting enzyme function provides a more significant characterization of cell death than the commonly used apoptotic death phenotypes.


Jurkat Cell Caspase Inhibitor Apoptotic Death Chloromethyl Ketone Granule Exocytosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alnemri, E.S., Livingston, DJ., Thornberry, N.A., Wong, W.W., and Yuan, J. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171.PubMedCrossRefGoogle Scholar
  2. Armstrong, R.C., Aka, T., Xiang, J., Gaur, S., Krebs, J.F., Hoang, K., Bai, X., Korsmeyer, S.J., Karanewsky, D.S., Fritz, L.C., and Tomaselli, K.J. (1996). Fas-induced activation of the cell death-related protease CPP-32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 271, 16850–16855.PubMedCrossRefGoogle Scholar
  3. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORTl/FADD-interacting protease, in Fas/APO-1 — and TNF receptor-induced cell death. Cell 85, 803–815.PubMedCrossRefGoogle Scholar
  4. Bump, N.J., Hackett, M., Hugunin, M., Seshagiri, S., Brady, K., Chen, P., Ferenz, C., Franklin, S., Ghayur, T., Li, P., et al. (1995). Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269, 1885–1888.PubMedCrossRefGoogle Scholar
  5. Cain, K., Inayat-Hussain, S.H., Couet, C., and Cohen, G.M. (1996). A cleavage-site-directed inhibitor of interleukin 1 β-converting enzyme-like proteases inhibits apoptosis in primary cultures of rat hepatocytes. Biochem. J. 314, 27–32.PubMedGoogle Scholar
  6. Fearnhead, H.O., Dinsdale, D., and Cohen, G.M. (1995). An interleukin-1-beta converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett. 375, 283–288.PubMedCrossRefGoogle Scholar
  7. Hay, B.A., Wolff, T., and Rubin, G.M. (1994). Expression of baculovirus p35 prevents cell death in Drosophila. Development 120, 2121–2129.PubMedGoogle Scholar
  8. Hengartner, M.O. and Horvitz, H.R. (1994). Programmed cell death in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 4, 581–586.PubMedCrossRefGoogle Scholar
  9. Henkart, P.A. (1994). Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules. Immunity 1, 343–346.PubMedCrossRefGoogle Scholar
  10. Henkart, P.A. (1996). ICE Family Proteases: Mediators of all apoptotic cell death? (Review). Immunity 4, 195–201.PubMedCrossRefGoogle Scholar
  11. Jacobson, M.D., Weil, M., and Raff, M.C. (1996). Role of Ced3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell Biol. 133, 1041–1051.CrossRefGoogle Scholar
  12. Lagasse, E. and Weissman, I.L. (1994). bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179, 1047–1052.PubMedCrossRefGoogle Scholar
  13. Lennon, S.V., Martin, S.J., and Cotter, T.G. (1991). Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif. 24, 203–214.PubMedCrossRefGoogle Scholar
  14. Liles, WC., Kiener, P.A., Ledbetter, J.A., Aruffo, A., and Klebanoff, S.J. (1996). Differential expression of Fas (CD95) and Fas Ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429–440.PubMedCrossRefGoogle Scholar
  15. Memon, S.A., Moreno, M.B., Petrak, D., and Zacharchuk, C.M. (1995a). Bcl-2 blocks glucocorticoid-but not Fasor activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155, 4644–4652.PubMedGoogle Scholar
  16. Memon, S.A., Petrak, D., Moreno, M.B., and Zacharchuk, C.M. (1995b). A simple assay for examining the effect of transiently expressed genes on programmed cell death. J. Immunol. Methods 180, 15–24.PubMedCrossRefGoogle Scholar
  17. Meredith, J.E., Fazeli, B., and Schwartz, M.A. (1993). The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4, 953–961.PubMedGoogle Scholar
  18. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O’Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., Mann, M., Krammer, P.H., Peter, M.E., and Dixit, V.M. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 85, 817–827.PubMedCrossRefGoogle Scholar
  19. Nakajima, H., Golstein, P., and Henkart, P.A. (1995). The target cell nucleus is not required for cell-mediated granzyme-or Fas-based cytotoxicity. J. Exp. Med. 181, 1905–1909.PubMedCrossRefGoogle Scholar
  20. Pronk, G.J., Ramer, K., Amiri, P., and Williams, L.T. (1996). Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271, 808–810.PubMedCrossRefGoogle Scholar
  21. Ray, C.A., Black, R.A., Kronheim, S.R., Greenstreet, T.A., Sleath, P.R., Salvesen, G.S., and Pickup, DJ. (1992). Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1B converting enzyme. Cell 69, 597–604.PubMedCrossRefGoogle Scholar
  22. Rouvier, E., Luciani, M.F., and Golstein, P. (1993). Fas involvement in Ca+2-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195–200.PubMedCrossRefGoogle Scholar
  23. Sarin, A., Wu, M.-L., and Henkart, P.A. (1996). Different ICE-family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184.Google Scholar
  24. Segal, D.M. and Wunderlich, J.R. (1988). Targeting of Cytotoxic Cells with Heterocrosslinked Antibodies. Cancer Invest. 6, 83–92.PubMedCrossRefGoogle Scholar
  25. Shimizu, S., Eguchi, Y., Kamiike, W., Waguri, S., Uchiyama, Y., Matsuda, H., and Tsujimoto, Y. (1996). Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13, 21–29.PubMedGoogle Scholar
  26. Strasser, A., Harris, A.W., Huang, D.C.S., Krammer, P.H., and Cory, S. (1995). Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136–6147.PubMedGoogle Scholar
  27. Sugimoto, A., Friesen, P.D., and Rothman, J.H. (1994). Baculovirus p35 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode Caenorhabditis elegans. EMBO J. 13, 2023–2028.PubMedGoogle Scholar
  28. Tadakuma, T., Kizaki, H., Odaka, C., Kubota, R., Ishimura, Y, Yagita, H., and Okumura, K. (1990). CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody. Eur. J. Immunol. 20, 779–784.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Apurva Sarin
    • 1
  • Klaus Ebnet
    • 1
  • Charles M. Zacharchuk
    • 2
  • Pierre A. Henkart
    • 1
  1. 1.Experimental Immunology BranchNational Cancer Institute National Institutes of HealthBethesdaUSA
  2. 2.Laboratory of Immune Cell BiologyNational Cancer Institute National Institutes of HealthBethesdaUSA

Personalised recommendations